A controversial program that would have led to pharmacists receiving $275 from Philip Morris when they order its VEEV vapes has been paused, amid growing concern about the ethics of the tobacco giant incentivising the sale and promotion of its products.
The scheme, first reported by News Corp, would have seen pharmacists receive $5 every time they dispense a new VEEV script, $10 for educating a new patient about the device, and $5 for referring patients to a doctor to obtain a prescription. Pharmacists would also receive a $275 payment for placing an initial stock order.
